Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Neuropharmacology. 2013 Oct 10;0:10.1016/j.neuropharm.2013.09.026. doi: 10.1016/j.neuropharm.2013.09.026

Table 4.

Social interaction data after D1 agonist infusion.

anatomical hits cage area time (s) corners time (s) open field interaction ratio
empty cage novel mouse empty cage novel mouse center time (s) distance (m) cage area corners

females aCSF (n=10) 106.01 ± 8.87 111.98 ± 8.74 4.44 ± 1.61 7.12 ± 3.06 24.78 ± 5.15 22.91 ± 2.73 109.09 ± 8.03 194.44 ± 61.26
5ng (n=8) 87.69 ± 13.85 103.20 ± 18.20 7.84 ± 1.71 6.06 ± 2.57 39.76 ± 10.15 20.15 ± 2.44 153.53 ± 43.10 328.68 ± 252.95
50ng (n=7) 90.09 ± 7.37 120.23 ± 10.75 11.87 ± 3.59 6.10 ± 3.84 23.23 ± 4.78 20.10 ± 4.19 135.66 ± 9.92 66.33 ± 19.95
500ng (n=9) 79.96 ± 11.43 62.99 ± 11.01* 8.30 ± 2.47 10.49 ± 3.12 32.59 ± 7.33 24.15 ± 4.02 84.04 ± 10.22* 164.24 ± 54.17
males aCSF (n=7) 76.39 ± 11.11 88.47 ± 20.18 11.07 ± 1.71 34.90 ± 22.14 31.83 ± 7.99 16.20 ± 1.59 105.75 ± 17.30 263.92 ± 175.41
5ng (n=8) 67.84 ± 9.05 93.08 ± 17.21 15.36 ± 3.64 8.89 ± 3.01 22.38 ± 4.61 20.23 ± 3.01 149.52 ± 28.66 82.41 ± 27.66
50ng (n=8) 75.15 ± 11.32 80.34 ± 19.11 8.83 ± 2.82 5.56 ± 1.58 31.08 ± 3.89 15.37 ± 2.32 102.97 ± 17.81 169.21 ± 94.90
500ng (n=6) 66.60 ± 13.00 77.33 ± 16.51 19.08 ± 9.54 33.33 ± 28.41 33.52 ± 5.18 14.44 ± 2.32 124.36 ± 39.38 227.65 ± 116.02
anatomical misses
females aCSF (n=8) 91.43 ± 8.77 115.63 ± 8.94 4.26 ± 1.53 1.71 ± 0.86 25.03 ± 1.96 19.01 ± 1.96 129.08 ± 6.94 105.71 ± 80.94
5ng (n=5) 80.90 ± 14.96 120.94 ± 19.51 11.26 ± 4.99 3.22 ± 1.66 33.24 ± 5.26 19.94 ± 3.72 163.85 ± 35.47 105.55 ± 86.63
50ng (n=5) 58.46 ± 14.30 83.40 ± 15.75 9.46 ± 2.10 6.12 ± 1.63 28.68 ± 6.17 25.59 ± 6.39 157.64 ± 32.96 63.07 ± 17.03
500ng (n=3) 79.53 ± 6.30 89.37 ± 42.51 10.27 ± 3.50 5.03 ± 3.98 23.10 ± 3.98 16.75 ± 4.25 111.84 ± 54.09 111.86 ± 101.57
*

p < 0.05 vs aCSF